Featured
-
-
Article |
A year-long extended release nanoformulated cabotegravir prodrug
Nanoformulated long-acting cabotegravir prodrugs are shown to be capable of extending the native drug’s antiretroviral activity, biodistribution and pharmacokinetics for up to 12 months in mice and rhesus macaques.
- Tanmay A. Kulkarni
- , Aditya N. Bade
- & Howard E. Gendelman